Schlagwort(e):
Pharmacology.
;
Clinical biochemistry.
;
Pharmacy.
;
Pharmacology.
;
Medical Biochemistry.
;
Pharmacy.
Beschreibung / Inhaltsverzeichnis:
Dedication -- Preface.-The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.
Kurzfassung:
This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
Materialart:
Online-Ressource
Seiten:
XII, 288 p. 38 illus., 22 illus. in color.
,
online resource.
Ausgabe:
1st ed. 2021.
ISBN:
9783030795115
Serie:
Progress in Drug Research, 75
URL:
https://doi.org/10.1007/978-3-030-79511-5
DOI:
10.1007/978-3-030-79511-5
DDC:
615
Sprache:
Englisch
Permalink
